Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 9:
Gain Therapeutics, Inc. GANX: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.
Gain Therapeutics, Inc. Price and Consensus
Gain Therapeutics, Inc. price-consensus-chart | Gain Therapeutics, Inc. Quote
Gain Therapeutics’ shares gained 23.9% over the last three months compared with the S&P 500’s advanced of 2.2%. The company possesses a Momentum Score of B.
Gain Therapeutics, Inc. Price
Gain Therapeutics, Inc. price | Gain Therapeutics, Inc. Quote
First Hawaiian, Inc. FHB: This bank holding company for First Hawaiian Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.
First Hawaiian, Inc. Price and Consensus
First Hawaiian, Inc. price-consensus-chart | First Hawaiian, Inc. Quote
First Hawaiian’s shares gained 10.5% over the last three months compared with the S&P 500’s advanced of 2.2%. The company possesses a Momentum Score of A.
First Hawaiian, Inc. Price
First Hawaiian, Inc. price | First Hawaiian, Inc. Quote
The Travelers Companies, Inc. TRV: This insurance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.6% over the last 60 days.
The Travelers Companies, Inc. Price and Consensus
The Travelers Companies, Inc. price-consensus-chart | The Travelers Companies, Inc. Quote
The Travelers Companies’ shares gained 4.6% over the last three months compared with the S&P 500’s advanced of 2.2%. The company possesses a Momentum Score of B.
The Travelers Companies, Inc. Price
The Travelers Companies, Inc. price | The Travelers Companies, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Research Chief Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
The Travelers Companies, Inc. (TRV) : Free Stock Analysis Report
First Hawaiian, Inc. (FHB) : Free Stock Analysis Report
Gain Therapeutics, Inc. (GANX) : Free Stock Analysis Report